Afya Limited(AFYA)Earnings, Financials & Key Ratios
AFYA•NASDAQ
$14.22
$667M mkt cap·10.1× P/E·Price updated May 6, 2026
SectorConsumer DefensiveIndustryEducation & TrainingSub-IndustryDegree-Granting Colleges and Universities
AboutAfya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.Show more
- Revenue$3.3B+14.9%
- EBITDA$1.22B+15.1%
- Net Income$632M+63.5%
- EPS (Diluted)6.93+62.3%
- Gross Margin63.21%+2.9%
- EBITDA Margin36.81%+0.2%
- Operating Margin30.63%+14.8%
- Net Margin19.11%+42.3%
- ROE15.88%+41.7%
- ROIC12.3%+13.8%
- Debt/Equity0.74+0.2%
- Interest Coverage2.76+39.1%
AFYA Key Insights
Afya Limited (AFYA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 32.6%
- ✓FCF machine: 31.5% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 34.5%
- ✓Healthy 5Y average net margin of 17.2%
- ✓Trading at only 1.5x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AFYA Price & Volume
Afya Limited (AFYA) stock price & volume — 10-year historical chart
Loading chart...
AFYA Growth Metrics
Afya Limited (AFYA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years34.5%
3 Years24.33%
TTM14.07%
Profit CAGR
10 Years-
5 Years32.62%
3 Years41.41%
TTM25.84%
EPS CAGR
10 Years-
5 Years27.96%
3 Years43%
TTM25.63%
Return on Capital
10 Years23.66%
5 Years11.39%
3 Years12.43%
Last Year14.24%
AFYA Recent Earnings
Afya Limited (AFYA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Mar 12, 2026EPS
$0.41
Est $0.38
+7.9%
Revenue
$166M
Est $168M
-0.8%
Q4 2025
Nov 12, 2025EPS
$0.38
Est $0.32
+18.8%
Revenue
$174M
Est $175M
-0.3%
Q3 2025
Aug 13, 2025EPS
$0.40
Est $0.40
+0.0%
Revenue
$169M
Est $173M
-2.2%
Q2 2025
May 8, 2025EPS
$0.55
Est $0.46
+19.6%
Revenue
$160M
Est $165M
-3.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 12, 2026 | $0.41vs $0.38+7.9% | $166Mvs $168M-0.8% |
| Q4 2025 | Nov 12, 2025 | $0.38vs $0.32+18.8% | $174Mvs $175M-0.3% |
| Q3 2025 | Aug 13, 2025 | $0.40vs $0.40+0.0% | $169Mvs $173M-2.2% |
| Q2 2025 | May 8, 2025 | $0.55vs $0.46+19.6% | $160Mvs $165M-3.1% |
Based on last 12 quarters of dataView full earnings history →
AFYA Peer Comparison
Afya Limited (AFYA) competitors in Degree-Granting Colleges and Universities — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PRDO | 2.14B | 34.11 | 14.10 | 24.2% | 18.9% | 16.3% | 0.11 | |
 LAUR | 4.64B | 32.52 | 17.21 | 8.64% | 16.08% | 25.36% | 0.71 | |
 STRA | 1.79B | 78.58 | 14.50 | 3.96% | 10.21% | 7.85% | 0.07 | |
 GHC | 4.88B | 1122.64 | 16.89 | 2.52% | 7.94% | 6.39% | 0.36 | |
 LOPE | 4.47B | 164.51 | 21.34 | 7.07% | 26.92% | 29.53% | 0.27 | |
 APEI | 1.01B | 55.91 | 41.11 | 3.89% | 2.15% | 10.92% | 0.23 | |
 UTI | 2.03B | 36.92 | 32.67 | 14.05% | 4.91% | 13.02% | 0.85 | |
 COUR | 1.02B | 6.03 | -19.45 | 9.04% | -8.23% | -10.06% | 0.01 |
Compare AFYA vs Peers
Afya Limited (AFYA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AFYA Income Statement
Afya Limited (AFYA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 216.01M | 333.94M | 750.63M | 1.2B | 1.72B | 2.33B | 2.88B | 3.3B | 3.63B |
| Revenue Growth % | - | 54.59% | 124.78% | 60.02% | 43.14% | 35.46% | 23.48% | 14.9% | 14.07% |
| Cost of Goods Sold | 124.06M | 168.05M | 308.85M | 434.65M | 652.3M | 859.55M | 1.11B | 1.22B | 1.27B |
| COGS % of Revenue | 57.44% | 50.32% | 41.15% | 36.19% | 37.94% | 36.91% | 38.59% | 36.79% | - |
| Gross Profit | 91.94M▲ 0% | 165.88M▲ 80.4% | 441.78M▲ 166.3% | 766.54M▲ 73.5% | 1.07B▲ 39.2% | 1.47B▲ 37.7% | 1.77B▲ 20.2% | 2.09B▲ 18.3% | 2.36B▲ 0% |
| Gross Margin % | 42.56% | 49.68% | 58.85% | 63.81% | 62.06% | 63.09% | 61.41% | 63.21% | 64.98% |
| Gross Profit Growth % | - | 80.42% | 166.32% | 73.51% | 39.21% | 37.71% | 20.18% | 18.27% | - |
| Operating Expenses | 42.6M | 69.44M | 236.53M | 403.2M | 626.18M | 805.58M | 999.04M | 1.08B | 1.17B |
| OpEx % of Revenue | 19.72% | 20.79% | 31.51% | 33.57% | 36.42% | 34.59% | 34.74% | 32.58% | - |
| Selling, General & Admin | 45.35M | 70.03M | 239.12M | 402.86M | 622.62M | 798.15M | 1.01B | 1.07B | 1.15B |
| SG&A % of Revenue | 21% | 20.97% | 31.86% | 33.54% | 36.21% | 34.27% | 35.28% | 32.31% | - |
| Research & Development | 0 | 0 | 0 | 32K | 0 | 9.44M | 21.5M | 20.09M | 4.26M |
| R&D % of Revenue | - | - | - | 0% | - | 0.41% | 0.75% | 0.61% | - |
| Other Operating Expenses | -2.75M | -599K | -2.59M | 347K | 3.56M | 0 | -37.15M | -11M | -1.31M |
| Operating Income | 49.34M▲ 0% | 96.45M▲ 95.5% | 205.25M▲ 112.8% | 363.33M▲ 77.0% | 440.89M▲ 21.3% | 664.1M▲ 50.6% | 767.06M▲ 15.5% | 1.01B▲ 31.9% | 1.19B▲ 0% |
| Operating Margin % | 22.84% | 28.88% | 27.34% | 30.25% | 25.64% | 28.51% | 26.67% | 30.63% | 32.84% |
| Operating Income Growth % | - | 95.46% | 112.81% | 77.02% | 21.35% | 50.63% | 15.5% | 31.95% | - |
| EBITDA | 53.52M | 106.07M | 278.4M | 472.84M | 595.12M | 876.04M | 1.06B | 1.22B | 1.52B |
| EBITDA Margin % | 24.78% | 31.76% | 37.09% | 39.36% | 34.61% | 37.61% | 36.74% | 36.81% | 41.94% |
| EBITDA Growth % | - | 98.18% | 162.47% | 69.84% | 25.86% | 47.21% | 20.61% | 15.11% | 21.8% |
| D&A (Non-Cash Add-back) | 4.18M | 9.62M | 73.15M | 109.5M | 154.22M | 211.94M | 289.51M | 204.12M | 330.61M |
| EBIT | 49.34M | 96.45M | 242.41M | 363.33M | 449.11M | 717.09M | 815.88M | 1.01B | 1.28B |
| Net Interest Income | -381K | -573K | -51.38M | -9.22M | -152.61M | -261.45M | -279.17M | -322.94M | -339.64M |
| Interest Income | 3.17M | 4.36M | 9.04M | 7.05M | 23.04M | 27.2M | 107.12M | 43.42M | 141.31M |
| Interest Expense | 1.04M | 2.4M | 15.94M | 16.27M | 175.65M | 288.65M | 386.3M | 366.35M | 480.88M |
| Other Income/Expense | 1.64M | 2.27M | -18.31M | -28.28M | -167.43M | -235.67M | -337.48M | -335.72M | -381.41M |
| Pretax Income | 50.98M▲ 0% | 98.72M▲ 93.7% | 186.94M▲ 89.4% | 335.05M▲ 79.2% | 273.46M▼ 18.4% | 428.43M▲ 56.7% | 429.58M▲ 0.3% | 676.39M▲ 57.5% | 811.83M▲ 0% |
| Pretax Margin % | 23.6% | 29.56% | 24.9% | 27.89% | 15.9% | 18.4% | 14.94% | 20.47% | 22.34% |
| Income Tax | 2.5M | 3.99M | 14.18M | 27.07M | 31.18M | 35.68M | 24.17M | 27.47M | 64.55M |
| Effective Tax Rate % | 4.9% | 4.04% | 7.58% | 8.08% | 11.4% | 8.33% | 5.63% | 4.06% | 7.95% |
| Net Income | 45.39M▲ 0% | 86.35M▲ 90.2% | 153.92M▲ 78.2% | 292.07M▲ 89.8% | 223.33M▼ 23.5% | 373.57M▲ 67.3% | 386.32M▲ 3.4% | 631.51M▲ 63.5% | 729.42M▲ 0% |
| Net Margin % | 21.01% | 25.86% | 20.5% | 24.32% | 12.99% | 16.04% | 13.43% | 19.11% | 20.08% |
| Net Income Growth % | - | 90.23% | 78.24% | 89.76% | -23.54% | 67.28% | 3.41% | 63.47% | 25.84% |
| Net Income (Continuing) | 48.48M | 94.73M | 172.76M | 307.99M | 242.28M | 392.76M | 405.42M | 648.92M | 747.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 651K | 88.37M | 48.63M | 51.56M | 51.87M | 51.32M | 41.51M | 40.63M | 40.52M |
| EPS (Diluted) | 0.52▲ 0% | 0.98▲ 88.5% | 2.02▲ 106.1% | 3.12▲ 54.5% | 2.37▼ 24.0% | 4.15▲ 75.1% | 4.27▲ 2.9% | 6.93▲ 62.3% | 7.99▲ 0% |
| EPS Growth % | - | 88.46% | 106.12% | 54.46% | -24.04% | 75.11% | 2.89% | 62.3% | 25.63% |
| EPS (Basic) | 0.52 | 0.98 | 2.03 | 3.15 | 2.39 | 4.15 | 4.27 | 7.01 | - |
| Diluted Shares Outstanding | 87.68M | 87.68M | 76.19M | 93.64M | 94.1M | 89.94M | 90.54M | 91.15M | 91.32M |
| Basic Shares Outstanding | 87.68M | 87.68M | 75.97M | 92.68M | 93.29M | 89.94M | 90.47M | 90.12M | 90.76M |
| Dividend Payout Ratio | - | - | 24.69% | - | - | - | - | - | - |
AFYA Balance Sheet
Afya Limited (AFYA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 60.48M | 133.5M | 1.11B | 1.41B | 1.21B | 1.64B | 1.2B | 1.59B | 1.76B |
| Cash & Short-Term Investments | 25.49M | 62.26M | 943.21M | 1.05B | 748.56M | 1.09B | 553.03M | 911.01M | 996.83M |
| Cash Only | 25.49M | 62.26M | 943.21M | 1.05B | 748.56M | 1.09B | 553.03M | 911.01M | 996.83M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 31.13M | 58.45M | 125.44M | 302.32M | 403.93M | 480.64M | 546.44M | 621.62M | 716.92M |
| Days Sales Outstanding | 52.6 | 63.88 | 61 | 91.86 | 85.75 | 75.32 | 69.35 | 68.67 | 68.53 |
| Inventory | 448K | 1.11M | 3.93M | 7.51M | 11.83M | 12.19M | 1.38M | 0 | 0 |
| Days Inventory Outstanding | 1.32 | 2.42 | 4.65 | 6.31 | 6.62 | 5.18 | 0.45 | - | - |
| Other Current Assets | 3.41M | 11.12M | 164.62M | 50.63M | 42.53M | 51.74M | 102.66M | 57.15M | 48.52M |
| Total Non-Current Assets | 43.15M | 784.92M | 1.8B | 3.39B | 5.24B | 5.56B | 6.38B | 7.24B | 7.42B |
| Property, Plant & Equipment | 32.48M | 65.76M | 413.6M | 679.46M | 1.08B | 1.23B | 1.38B | 1.5B | 1.6B |
| Fixed Asset Turnover | 6.65x | 5.08x | 1.81x | 1.77x | 1.59x | 1.89x | 2.09x | 2.20x | 2.36x |
| Goodwill | 0 | 169.53M | 459.41M | 810.66M | 1.18B | 1.26B | 1.33B | 1.53B | 1.53B |
| Intangible Assets | 4.73M | 512.93M | 852.93M | 1.76B | 2.72B | 2.78B | 3.46B | 4.01B | 4.05B |
| Long-Term Investments | 3.26M | 26.31M | 45.63M | 51.41M | 48.48M | 53.91M | 51.83M | 54.44M | 217.39M |
| Other Non-Current Assets | 5.94M | 36.69M | 19.32M | 76.09M | 207.75M | 234.32M | 156.83M | 151.82M | 608.5M |
| Total Assets | 103.63M▲ 0% | 918.42M▲ 786.3% | 2.91B▲ 217.1% | 4.79B▲ 64.6% | 6.45B▲ 34.5% | 7.2B▲ 11.7% | 7.58B▲ 5.3% | 8.83B▲ 16.4% | 9.19B▲ 0% |
| Asset Turnover | 2.08x | 0.36x | 0.26x | 0.25x | 0.27x | 0.32x | 0.38x | 0.37x | 0.40x |
| Asset Growth % | - | 786.29% | 217.12% | 64.57% | 34.51% | 11.67% | 5.35% | 16.42% | 57.99% |
| Total Current Liabilities | 51.94M | 182.33M | 333.23M | 589.38M | 766.51M | 905.69M | 1.06B | 1.14B | 1.8B |
| Accounts Payable | 6.74M | 8.1M | 149.51M | 224.16M | 298.95M | 333.19M | 108.22M | 128.08M | 249.13M |
| Days Payables Outstanding | 19.83 | 17.6 | 176.69 | 188.24 | 167.28 | 141.49 | 35.59 | 38.46 | 74.02 |
| Short-Term Debt | 1.16M | 26.8M | 53.61M | 117.67M | 143.2M | 207.38M | 179.25M | 363.55M | 916.83M |
| Deferred Revenue (Current) | 8.25M | 13.74M | 36.86M | 63.84M | 114.58M | 133.05M | 0 | 0 | 417.16M |
| Other Current Liabilities | 24.14M | 108.99M | 47.9M | 84.19M | 146.46M | 157.24M | 514.14M | 361.45M | 293.69M |
| Current Ratio | 1.16x | 0.73x | 3.34x | 2.38x | 1.57x | 1.81x | 1.14x | 1.39x | 1.39x |
| Quick Ratio | 1.16x | 0.73x | 3.32x | 2.37x | 1.56x | 1.79x | 1.14x | 1.39x | 1.39x |
| Cash Conversion Cycle | 34.09 | 48.7 | -111.05 | -90.07 | -74.91 | -60.99 | 34.21 | - | -5.49 |
| Total Non-Current Liabilities | 4.92M | 145.73M | 465.5M | 1.37B | 2.68B | 3.04B | 2.88B | 3.38B | 2.6B |
| Long-Term Debt | 2.66M | 51.03M | 6.75M | 576M | 1.3B | 1.74B | 1.62B | 1.83B | 996.84M |
| Capital Lease Obligations | 0 | 0 | 261.82M | 385.73M | 689.13M | 737.07M | 837.67M | 932.76M | 3.84B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.26M | 94.7M | 196.93M | 408.21M | 687.35M | 568.93M | 423.71M | 614.4M | 2.41B |
| Total Liabilities | 56.86M | 328.06M | 798.73M | 1.96B | 3.45B | 3.95B | 3.94B | 4.52B | 4.4B |
| Total Debt | 3.82M | 77.83M | 344.87M | 1.14B | 2.16B | 2.71B | 2.68B | 3.17B | 2.97B |
| Net Debt | -21.67M | 15.57M | -598.34M | 96.33M | 1.41B | 1.62B | 2.12B | 2.26B | 1.98B |
| Debt / Equity | 0.08x | 0.13x | 0.16x | 0.40x | 0.72x | 0.84x | 0.73x | 0.74x | 0.74x |
| Debt / EBITDA | 0.07x | 0.73x | 1.24x | 2.41x | 3.63x | 3.10x | 2.53x | 2.61x | 1.95x |
| Net Debt / EBITDA | -0.40x | 0.15x | -2.15x | 0.20x | 2.37x | 1.85x | 2.01x | 1.86x | 1.86x |
| Interest Coverage | 47.35x | 40.12x | 12.88x | 22.33x | 2.51x | 2.30x | 1.99x | 2.76x | 2.66x |
| Total Equity | 46.76M▲ 0% | 590.35M▲ 1162.5% | 2.11B▲ 258.0% | 2.83B▲ 34.1% | 3B▲ 5.9% | 3.25B▲ 8.3% | 3.64B▲ 12.1% | 4.31B▲ 18.3% | 4.79B▲ 0% |
| Equity Growth % | - | 1162.47% | 258.04% | 34.07% | 5.87% | 8.34% | 12.09% | 18.32% | 64.06% |
| Book Value per Share | 0.53 | 6.73 | 27.74 | 30.26 | 31.88 | 36.14 | 40.24 | 47.29 | 52.42 |
| Total Shareholders' Equity | 46.11M | 501.98M | 2.07B | 2.78B | 2.95B | 3.2B | 3.6B | 4.27B | 4.75B |
| Common Stock | 66.48M | 315M | 17K | 17K | 17K | 17K | 17K | 17K | 17K |
| Retained Earnings | 40.31M | 52.58M | 115.92M | 407.99M | 631.32M | 1B | 1.38B | 2.01B | 2.46B |
| Treasury Stock | 0 | 0 | 0 | 0 | -152.63M | -304.95M | -299.15M | -273.95M | -240.14M |
| Accumulated OCI | 43.21M | 59.81M | 115.92M | 50.72M | 0 | 0 | 0 | 187.5M | 0 |
| Minority Interest | 651K | 88.37M | 48.63M | 51.56M | 51.87M | 51.32M | 41.51M | 40.63M | 40.52M |
AFYA Cash Flow Statement
Afya Limited (AFYA) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 39.92M | 80.32M | 299.22M | 371.51M | 630.87M | 843.9M | 1.04B | 1.43B | 1.43B |
| Operating CF Margin % | 18.48% | 24.05% | 39.86% | 30.93% | 36.69% | 36.23% | 36.29% | 43.36% | - |
| Operating CF Growth % | - | 101.21% | 272.54% | 24.16% | 69.81% | 33.77% | 23.67% | 37.28% | 3622.66% |
| Net Income | 50.98M | 98.72M | 186.94M | 335.05M | 273.46M | 428.43M | 429.58M | 676.39M | 729.42M |
| Depreciation & Amortization | 4.02M | 9.08M | 73.15M | 108.74M | 154.22M | 206.22M | 289.51M | 333.34M | 365.32M |
| Stock-Based Compensation | 0 | 2.16M | 18.11M | 32.61M | 43.38M | 31.27M | 31.54M | 32.42M | 22.81M |
| Deferred Taxes | 0 | 5.29M | -9.86M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -427K | 1.5M | 55.47M | 64.24M | 208.6M | 287.89M | 352.39M | 409.87M | 542.15M |
| Working Capital Changes | -14.66M | -36.44M | -24.6M | -169.14M | -48.8M | -109.92M | -59.39M | -19.36M | -174.42M |
| Change in Receivables | -9.79M | -28.2M | -35.56M | -178M | -81.99M | -129.16M | -131.34M | -79.34M | -205.91M |
| Change in Inventory | -140K | -593K | -236K | -3.11M | -3.72M | -363K | 10.95M | 0 | -1.15M |
| Change in Payables | -2.38M | -1.53M | 3.03M | 4.47M | 14.48M | 9.97M | 24.5M | 18.13M | 14.24M |
| Cash from Investing | -22.07M | -262.39M | -354.15M | -1.04B | -1.27B | -591.47M | -1.14B | -1.09B | -594.11M |
| Capital Expenditures | -21.07M | -21.69M | -121.71M | -89.83M | -125.87M | -297.02M | -118.44M | -136.92M | -167.2M |
| CapEx % of Revenue | 9.75% | 6.49% | 16.21% | 7.48% | 7.32% | 12.75% | 4.12% | 4.14% | - |
| Acquisitions | 0 | -221.3M | -241.57M | -919.97M | -1.01B | -301.2M | -907.52M | -627.57M | -215.6M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -1M | -19.4M | 9.13M | -32.97M | -143.17M | 6.75M | -117.09M | -327.12M | -211.31M |
| Cash from Financing | -4.13M | 218.84M | 921.43M | 756.42M | 364.68M | 92.94M | -439.94M | 23.97M | -806.2M |
| Debt Issued (Net) | -1.62M | 68.38M | -107.49M | 394.5M | 681.7M | 466.58M | -138.81M | 321.68M | -352.35M |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | -1000K | -1000K | -1000K | 0 | 0 |
| Dividends Paid | 0 | 0 | -38.75M | 0 | 0 | 0 | 0 | 0 | -129.01M |
| Share Repurchases | 0 | 0 | 0 | 0 | -213.72M | -152.32M | -12.37M | 0 | 0 |
| Other Financing | -2.51M | 150.46M | 36.15M | -27.24M | -103.3M | -221.32M | -288.76M | -297.71M | -324.84M |
| Net Change in Cash | 13.72M▲ 0% | 36.77M▲ 168.0% | 880.95M▲ 2295.8% | 101.83M▼ 88.4% | -296.48M▼ 391.1% | 344.52M▲ 216.2% | -540.05M▼ 256.8% | 357.99M▲ 166.3% | 159.95M▲ 0% |
| Free Cash Flow | 18.85M▲ 0% | 58.63M▲ 211.0% | 177.51M▲ 202.8% | 233.92M▲ 31.8% | 354.07M▲ 51.4% | 546.88M▲ 54.5% | 798.2M▲ 46.0% | 1.04B▲ 30.3% | 1.26B▲ 0% |
| FCF Margin % | 8.73% | 17.56% | 23.65% | 19.47% | 20.59% | 23.48% | 27.75% | 31.48% | 34.56% |
| FCF Growth % | - | 211.02% | 202.75% | 31.78% | 51.36% | 54.46% | 45.96% | 30.3% | 53.61% |
| FCF per Share | 0.21 | 0.67 | 2.33 | 2.50 | 3.76 | 6.08 | 8.82 | 11.41 | 11.41 |
| FCF Conversion (FCF/Net Income) | 0.88x | 0.93x | 1.94x | 1.27x | 2.82x | 2.26x | 2.70x | 2.27x | 1.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.33M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AFYA Key Ratios
Afya Limited (AFYA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 27.11% | 11.38% | 11.81% | 7.66% | 11.95% | 11.21% | 15.88% | 16.05% |
| Return on Invested Capital (ROIC) | 22.93% | 14.51% | 12.26% | 9.01% | 10.73% | 10.82% | 12.3% | 12.3% |
| Gross Margin | 49.68% | 58.85% | 63.81% | 62.06% | 63.09% | 61.41% | 63.21% | 64.98% |
| Net Margin | 25.86% | 20.5% | 24.32% | 12.99% | 16.04% | 13.43% | 19.11% | 20.08% |
| Debt / Equity | 0.13x | 0.16x | 0.40x | 0.72x | 0.84x | 0.73x | 0.74x | 0.74x |
| Interest Coverage | 40.12x | 12.88x | 22.33x | 2.51x | 2.30x | 1.99x | 2.76x | 2.66x |
| FCF Conversion | 0.93x | 1.94x | 1.27x | 2.82x | 2.26x | 2.70x | 2.27x | 1.72x |
| Revenue Growth | 54.59% | 124.78% | 60.02% | 43.14% | 35.46% | 23.48% | 14.9% | 14.07% |
AFYA Frequently Asked Questions
Afya Limited (AFYA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Afya Limited (AFYA) reported $3.63B in revenue for fiscal year 2024. This represents a 1582% increase from $216.0M in 2017.
Afya Limited (AFYA) grew revenue by 14.9% over the past year. This is steady growth.
Yes, Afya Limited (AFYA) is profitable, generating $729.4M in net income for fiscal year 2024 (19.1% net margin).
Dividend & Returns
Afya Limited (AFYA) has a return on equity (ROE) of 15.9%. This is reasonable for most industries.
Afya Limited (AFYA) generated $1.26B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More AFYA
Afya Limited (AFYA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates